Chang Lu

1.1k total citations
41 papers, 619 citations indexed

About

Chang Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Chang Lu has authored 41 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 10 papers in Surgery. Recurrent topics in Chang Lu's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chang Lu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chang Lu collaborates with scholars based in China, United States and Taiwan. Chang Lu's co-authors include Chih‐Cheng Chen, Scott Richardson, Wen Song, Josiemer Mattei, Martha Taméz, Laila Al‐Shaar, Kelsey A. Vercammen, Hongtao Guo, Cih‐En Huang and Qing Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Cancer.

In The Last Decade

Chang Lu

36 papers receiving 614 citations

Peers

Countries citing papers authored by Chang Lu

Since Specialization

Citations

This map shows the geographic impact of Chang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Lu more than expected).

Fields of papers citing papers by Chang Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Lu. The network helps show where Chang Lu may publish in the future.

Co-authorship network of co-authors of Chang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Lu. A scholar is included among the top collaborators of Chang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Lu. Chang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer 2025 ·Nature Reviews Clinical Oncology ·(unknown), (unknown), Ji Chen, (unknown), Mei-Mei Zheng, Wu Lv, Chang Lu, Xue‐Wu Wei, Dongqing Cai, Zhi Guo, (unknown), Shichao Lv, Yu Deng, Zhihong Chen, Chong‐Rui Xu, Qing Zhou	3
2	Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial 2025 ·Phytomedicine ·(unknown), Hua Qu, Haiyan Guo, Ming Guo, Jiaqi Liang, Yue Niu, (unknown), Xin Wang, Yafei Li, Hongyan Jiang, Jinhui Ma, Zhipeng Wang, (unknown), Chang Lu, Dazhuo Shi	0
3	Does subjective life expectancy matter in purchasing life insurance among middle-aged and older adult? Evidence from China 2024 ·Frontiers in Public Health ·Xuejiao Chen, (unknown), Chang Lu, (unknown), (unknown)	3
4	Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes 2024 ·Diabetes Care ·Zsu‐Zsu Chen, Chang Lu, Jonathan M. Dreyfuss, (unknown), Xu Shi, Shuning Zheng, (unknown), Laura Pyle, Petter Bjornstad, Laure El ghormli, Robert E. Gerszten, Elvira Isganaitis	1
5	Gestational Diabetes, the Human Milk Metabolome, and Infant Growth and Adiposity 2024 ·JAMA Network Open ·Emily Nagel, (unknown), Jonathan M. Dreyfuss, Eric F. Lock, Kelsey E. Johnson, Chang Lu, David A. Fields, Ellen W. Demerath, Elvira Isganaitis	3
6	Silencing LncRNA SNHG14 alleviates renal tubular injury via the miR-483-5p/HDAC4 axis in diabetic kidney disease 2024 ·HORMONES ·(unknown), Tianyi Qiu, (unknown), Tongguan Tian, Dan Wang, Chang Lu	4
7	A New Porcine Reproductive and Respiratory Syndrome Virus with N-Linked Glycosylation Site Deletion in GP5 44th Amino Acid from JXA1, NADC30-Like, and JM Triparental Recombination 2023 ·Transboundary and Emerging Diseases ·Xingdong Zhou, (unknown), (unknown), Lujia Zhou, (unknown), (unknown), Chang Lu, (unknown), (unknown), (unknown), Yingshan Zhou, (unknown), (unknown), (unknown), Houhui Song	0
8	Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement 2023 ·Cancer Treatment and Research Communications ·(unknown), Fa-Man Xiao, (unknown), Yuqing Chen, Yufa Li, Chang Lu, Junwei Su, (unknown), Chanyuan Zhang, (unknown), (unknown), Yi‐Long Wu, Hua‐Jun Chen, Jin‐Ji Yang	0
9	Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non–Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705) 2022 ·Clinical Lung Cancer ·Si‐Yang Maggie Liu, Hong‐Hong Yan, Xue‐Wu Wei, Chang Lu, Xiaorong Dong, Yingying Du, Jiuwei Cui, Yuan Chen, Rui Ma, Buhai Wang, Zhen Zhou, Shundong Cang, Jin‐Ji Yang, Hai‐Yan Tu, Xuchao Zhang, Wen‐Zhao Zhong, Qing Zhou, Yi‐Long Wu	4
10	Factors associated with post-traumatic stress disorder of nurses exposed to corona virus disease 2019 in China 2020 ·Medicine ·(unknown), Hongtao Guo, (unknown), Wen Song, Chang Lu, (unknown)	82
11	Nontypeable Haemophilus influenzae DNA stimulates type I interferon expression via STING signaling pathway 2018 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Chang Lu, Xuemei Zhang, (unknown), Wenchun Xu, (unknown), Jin Cui, Yibing Yin, (unknown)	16
12	Co-occurring alterations in driver genes impact on EGFR-targeted therapy among patients with EGFR-mutant advanced non–small cell lung cancer 2018 ·Annals of Oncology ·Chang Lu, Jin‐Hyoung Kang, (unknown), Hai‐Yan Tu, Qing Zhou, (unknown), Yi‐Long Wu, Jin‐Ji Yang	1
13	Incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy 2018 ·Annals of Oncology ·Wen‐Chi Chou, (unknown), J.-S. Chen, Chang Lu, Pei‐Hung Chang, (unknown)	1
14	Health Effects and Public Health Concerns of Energy Drink Consumption in the United States: A Mini-Review 2017 ·Frontiers in Public Health ·Laila Al‐Shaar, Kelsey A. Vercammen, Chang Lu, Scott Richardson, Martha Taméz, Josiemer Mattei	87
15	Marijuana Use and Renal Function Among US Adults 2017 ·The American Journal of Medicine ·Chang Lu, Stefania Papatheodorou, John Danziger, Murray A. Mittleman	13
16	Incidence and risk factors for central venous access port-related infection in Chinese cancer patients 2015 ·Journal of the Formosan Medical Association ·(unknown), (unknown), (unknown), Min-Chi Chen, (unknown), (unknown), Feng-Che Kuan, Chih‐Cheng Chen, Chang Lu	27
17	Pedicle Screw Implantation in the Thoracic and Lumbar Spine of 1–4-Year-Old Children 2013 ·Journal of Spinal Disorders & Techniques ·Jing Li, Guohua Lü, Bin Wang, Xiaobin Wang, Chang Lu, Yijun Kang	13
18	A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer 2010 ·British Journal of Cancer ·(unknown), (unknown), Liqun Chen, Chung‐Jen Yen, (unknown), (unknown), (unknown), Chang Lu, (unknown), Yee Chao	14
19	Extrapulmonary Small Cell Carcinoma: A Review 2009 ·Chang Lu, (unknown), (unknown), (unknown), (unknown), (unknown)	2
20	The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003) 2008 ·Annals of Oncology ·(unknown), I‐Jung Feng, Chang Lu, Chih‐Cheng Chen, (unknown), Shih‐Hao Huang, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact